Advertisement

Inflammation in migraine pathogenesis: when, where, and how

  • Egilius L. H. Spierings
Chapter
  • 65 Downloads
Part of the Progress in Inflammation Research book series (PIR)

Abstract

Inflammation is one of the three mechanisms that are thought to be involved in the pathogenesis of the migraine headache and for which there is clinical experimental evidence. The other two mechanisms for which such evidence exists are extracranial arterial vasodilation and decreased inhibition of central pain transmission. In so-called migraine with aura, the headache is preceded by transient focal neurological symptoms, generally referred to as aura symptoms. In the following, the pathogenesis of the migraine headache, as well as that of the migraine aura, will be discussed. The traditional (sequential) concept of the pathogenesis of the migraine attack will be reviewed and an alternative (parallel) concept presented. Finally, the mode of action of the specific abortive antimigraine medications, the triptans and ergots, will be discussed on the basis of available experimental evidence in man.

Keywords

Cerebral Blood Flow Migraine Attack Migraine Headache Migraine With Aura Migraine Without Aura 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Graham JR, Wolff HG (1938) Mechanism of migraine headache and action of ergota-mine tartrate. Arch Neurol Psychiat 39: 737–763CrossRefGoogle Scholar
  2. 2.
    Schumacher GA, Wolff HG (1941) A. Contrast of histamine headache with the headache of migraine and that associated with hypertension. B. Contrast of vascular mechanisms in preheadache and in headache phenomena of migraine. Arch Neurol Psychiat 45: 199–214CrossRefGoogle Scholar
  3. 3.
    Ray BS, Wolff HG (1940) Pain-sensitive structures of the head and their significance in headache. Arch Surg 41: 813–856CrossRefGoogle Scholar
  4. 4.
    Tunis MM, Wolff HG (1953) Long-term observations of the reactivity of the cranial arteries in subjects with vascular headache of the migraine type. Arch Neurol Psychiat 70: 551–557CrossRefGoogle Scholar
  5. 5.
    Iversen HK, Nielsen TH, Olesen J, Tfelt-Hansen P (1990) Arterial responses during migraine headache. Lancet 336: 837–839PubMedCrossRefGoogle Scholar
  6. 6.
    De Hoon JNJM (2000) Migraine and anti-migraine drugs. Focus on cardiovascular aspects. Doctoral Thesis, Maastricht University, Maastricht, The NetherlandsGoogle Scholar
  7. 7.
    Chapman LF, Ramos AO, Goodell H, Wolff HG (1961) Neurohumoral features of afferent fibers in man. Their role in vasodilatation, inflammation, and pain. Arch Neurol 4: 49–82CrossRefGoogle Scholar
  8. 8.
    Wolff HG, Tunis MM, Goodell H (1953) Evidence of tissue damage and changes in pain sensitivity in subjects with vascular headache of the migraine type. Arch Int Med 92: 478–484CrossRefGoogle Scholar
  9. 9.
    Dalessio DJ (1972) Wolff’s headache and other head pain. Oxford University Press, New York, 272–307Google Scholar
  10. 10.
    Chapman LF, Ramos AO, Goodell H et al (1960) A humoral agent implicated in vascular headache of the migraine type. Arch Neurol 3: 223–229PubMedCrossRefGoogle Scholar
  11. 11.
    Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of human during migraine headache. Ann Neurol 28: 183–187PubMedCrossRefGoogle Scholar
  12. 12.
    Burnstein R, Yarnitsky D, Goor-Areyh I et al (2000) An association between migraine and cutaneous allodynia. Ann Neurol 47: 614–624CrossRefGoogle Scholar
  13. 13.
    Anselmi B, Baldi E, Casacci F, Salmon S (1980) Endogenous opioids in cerebrospinal fluid and blood in idiopathic headache sufferers. Headache 20: 294–299PubMedCrossRefGoogle Scholar
  14. 14.
    Marcussen RM, Wolff HG (1950) 1. Effects of carbon dioxide-oxygen mixtures given during preheadache phase of the migraine attack. 2. Further analysis of the pain mechanisms in headache. Arch Neurol Psychiat 63: 42–51PubMedCrossRefGoogle Scholar
  15. 15.
    Hare EH (1966) Personal observations on the spectral march of migraine. J Neurol Sci 3: 259–264PubMedCrossRefGoogle Scholar
  16. 16.
    Milner PM (1958) Note on a possible correspondence between the scotomas of migraine and spreading depression of Leão. Electroencephalogr Clin Neurophysiol 10: 705PubMedCrossRefGoogle Scholar
  17. 17.
    Olesen J, Friberg L, Olsen TS et al (1990) Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 28: 791–798PubMedCrossRefGoogle Scholar
  18. 18.
    Olesen J, Larsen B, Lauritzen M (1981) Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 9: 344–352PubMedCrossRefGoogle Scholar
  19. 19.
    Sanchez del Rio M, Bakker D, Wu O et al (1999) Perfusion weighted imaging during migraine: spontaneous visual aura and headache. Cephalalgia 19: 701–707PubMedCrossRefGoogle Scholar
  20. 20.
    Hadjikhani N, Sanchez del Rio M, Wu O et al (2001) Mechanisms of migraine aura revealed by fMRI in human visual cortex. Proc Natl Acad Sci USA 98: 4687–4692PubMedCrossRefGoogle Scholar
  21. 21.
    Welch KMA, Levine SR, D’Andrea G et al (1989) Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology 39: 538–541PubMedCrossRefGoogle Scholar
  22. 22.
    Spierings ELH (1988) Recent advances in the understanding of migraine. Headache 28: 655–658PubMedCrossRefGoogle Scholar
  23. 23.
    Palmer JE, Chronicle EP, Rolan P, Mulleners WM (2000) Cortical hyperexcitability is cortical under-inhibition: evidence from a novel functional test of migraine patients. Cephalalgia 20: 525–532PubMedCrossRefGoogle Scholar
  24. 24.
    Ophoff RA, Terwindt GM, Vergouwe MN et al (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87: 543–552PubMedCrossRefGoogle Scholar
  25. 25.
    Weiher C, May A, Limmroth V et al (1995) Brain stem activation in spontaneous human migraine attacks. Nature Med 1: 658–660CrossRefGoogle Scholar
  26. 26.
    May A, Kaube H, Buchel C et al (1998) Experimental cranial pain elicited by capsaicin: a PET study. Pain 74: 61–66PubMedCrossRefGoogle Scholar
  27. 27.
    Paulson PE, Minoshima S, Morrow TJ, Casey KL (1998) Gender differences in pain perception and patterns of cerebral activation during noxious heat stimulation in humans. Pain 76: 223–229PubMedCrossRefGoogle Scholar
  28. 28.
    Spierings ELH (2000) The (suma)triptan history revisited (letter). Headache 40: 766–767PubMedCrossRefGoogle Scholar
  29. 29.
    Spierings ELH, Saxena PR (1979) Effect of ergotamine on cranial arteriovenous shunting in experiments with constant flow perfusion. Eur J Pharmacol 56: 31–37PubMedCrossRefGoogle Scholar
  30. 30.
    Heyck H (1969) Pathogenesis of migraine. Res Clin Stud Headache 2: 1–28Google Scholar
  31. 31.
    Goadsby PJ, Edvinsson L (1991) Sumatriptan reverses the changes in calcitonin gene-related peptide seen in the headache phase of migraine. Cephalalgia 11 (Suppl 11): 3–4Google Scholar

Copyright information

© Springer Basel AG 2002

Authors and Affiliations

  • Egilius L. H. Spierings
    • 1
  1. 1.Brigham and Women’s HospitalHarvard Medical SchoolBostonUSA

Personalised recommendations